Aeglea BioTherapeutics, Inc.

Q2 2026 13F Holders

Symbol
SYRE
CUSIP
00773J202
Type
Equity
Class
COM NEW
Num filings
277
Total reported value, excl. options
$8.58 B
Manager Report Date Value ($000) Shares Option Type